Dr. Osama Giledi

[:en]]MBBch, FRCSEd
Consultant Ophthalmologist
Specialist in Cataract, Cornea and Refractive Vision Correction Surgery
GCAA Approved Specialist Aeromedical Medical Examiner
Associate Professor of Ophthalmology (Adjunct) Dr Osama Giledi is a highly experienced consultant ophthalmologist who specialises in Cornea, Anterior Segment, Cataract and Refractive Surgery. He is also skilled in managing ocular surface problems including severe dry eye and Stem cell deficiency.  He performs small incision phacoemulsification for his cataract surgery and is experienced in using toric and multifocal premium intraocular lenses. Dr Giledi expertise in managing complex corneal conditions includes all types of modern corneal graft procedures, such as DALK and DSAEK. He has performed more than 23,000 refractive surgeries including Lasik, LASEK, Intralase LASIK and Trans PRK, as well as phakic IOLs. He delivers the latest treatment for keratoconus including Intracorneal ring segments, corneal cross-linking and complex laser treatment.
Dr Giledi graduated from Libya and completed his ophthalmic training in the UK, attaining a Fellowship in Ophthalmology from The Royal College of Edinburgh in 1996. He completed 2 years of higher subspecialty training fellowship on the anterior segment, Cornea and refractive surgery on 2003 at the prestigeous Corneoplastic Unit and Eye Bank at Queen Victoria Hospital, East Grinstead. He worked as a Consultant Ophthalmologist at the Centre for Sight London and also at the Corneoplastic Unit and Eye Bank at Queen Victoria Hospital.  Dr Giledi relocated to Dubai on 2013 after 22 years’ experience in the UK, providing anterior segment, Cornea, Refractive and cataract surgery services.
In addition to his clinical commitments, Dr. Giledi has extensive experience in teaching and training, he is a noted presenter at national and international meetings, and he has an extensive body of research published in peer-reviewed scientific journals. He is a member of the Royal College Surgeons of Edinburgh, the United Kingdom & Ireland Society of Cataract and Refractive Surgeons, and the European Society of Cataract and Refractive Surgeons.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage[:ar]بكالوريوس في الطب والجراحة
زميل الكلية الملكية البريطانية للجراحين
استشاري طب العيون
أخصائي جراحة الكتاراكت والقرنية وتصحيح البصر
أخصائي فحص عيون معتمد من الهيئة العامة للطيران المدني
استاذ مشارك في طب العيون (ملحق)الدكتور أسامة الجليدي هو استشاري في طب العيون ويملك خبرة واسعة في مجالات جراحة القرنية والجزء الأمامي من العين وعلاج إعتام عدسة العين وجراحة تصحيح البصر. وهو أيضاً خبير في علاج مشاكل سطح العين، بما في ذلك جفاف العين الشديد ونقص الخلايا الجذعية. وتشمل خبرته إزالة إعتام عدسة العين بتقنية استحلاب عدسة العين أو phacoemulsification” “، بالإضافة استخدام العدسات المحدبة والعدسات الفائقة متعددة البؤر. يملك الدكتور الجليدي خبرة واسعة في تشخيص وعلاج مشاكل القرنية المعقدة، بما في ذلك إجراء عمليات زراعة القرنية الحديثة مثل زراعة القرنية الأمامية العميقة (DALK) و الزراعة الداخلية لخلايا القرنية (DSAEK). أجرى ما يزيد على 23,000 جراحة لتصحيح البصر بما في ذلك عمليات التصحيح بالليزر LASIK وLASEK وIntraLase LASIK وTrans PRK، إلى جانب زراعة عدسات العين (Phakic IOLs). ينفذ د. الجليدي أيضًا أحدث الأساليب لعلاج القرنية المخروطية، بما في ذلك الحلقات القرنية وتصليب القرنية والعلاج المعقد بالليزر.
تخرج الدكتور الجليدي في ليبيا وأنهى تخصصه في طب العيون في المملكة المتحدة، حيث حاز على زمالة طب العيون من الكلية الملكية بإدنبره سنة 1996. وفي عام 2003 أنهى عامين من متطلبات تدريب الزمالة في تخصص فرعي لجراحة الجزء الأمامي للعين والقرنية وجراحة تصحيح البصر، وذلك في وحدة الجراحة التجميلية للقرنية وبنك العيون في مستشفى الملكة فيكتوريا في إيست غرينستيد. شغل منصب استشاري طب العيون في مركز البصر بلندن وكذلك في في وحدة الجراحة التجميلية للقرنية وبنك العيون في مستشفى الملكة فيكتوريا. وانتقل الدكتور الجليدي إلى دبي في عام 2013 بعد خبرة 22 عامًا في المملكة المتحدة، ويجري حاليًا جراحات الجزء الأمامي للعين والقرنية وتصحيح البصر وإعتام عدسة العين.
وبالإضافة إلى مجال اختصاصه، يتمتع الدكتور أسامة الجليدي بخبرة واسعة في مجال التدريس والتدريب، كما يشارك كمتحدث في العديد من اللقاءات المحلية والدولية وله أبحاث ومؤلفات في مجلات طبية مرموقة. وهو عضو في الكلية الملكية للجراحين في إدنبرة، وفي جمعية المملكة المتحدة وإيرلندا لجراحي إعتام عدسة العين وتصحيح البصر، وفي الجمعية الأوروبية لجراحي إعتام عدسة العين وتصحيح البصر.
انقر  هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون[:]

Dr. Paola Salvetti

[:en] MD
Consultant Ophthalmologist
Specialist in Medical Retina
Clinical Lead Aviation Medicine
GCAA Approved Specialist Medical Examiner
CASA Designated Aviation Ophthalmologist Dr. Paola Salvetti is an experienced ophthalmologist and retina specialist with substantial clinical and research experience in the diagnosis and treatment of retina diseases, gained in the USA, France and Italy. In addition, Dr Salvetti has a special interest in aviation ophthalmology, neuroscience research and assessing and treating children with varying degrees of eyesight disability.
Dr. Salvetti studied medicine and ophthalmology in her native Italy prior to undertaking a fellowship at Harvard Medical School in Boston, USA. She was a Retina Fellow at the Schepens Eye Research Institute & Massachusetts Eye and Ear Infirmary, Harvard Medical School in Boston, before taking up a position as a General Ophthalmologist & Medical Retina Specialist and neurophthalmology physician in France; she was then appointed Medical Director of the Centro Oculistico Bergamasco in Italy.
Dr. Salvetti has undertaken a significant amount of published research work and presentations in her specialist areas and is a member of the Association of Research in Vision and Ophthalmology.
Click here to read more on Glaucoma.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage استشارية طب العيون
أخصائية علاج الشبكية
مسؤولة عن قسم طب الطيران المدني
أخصائية فحص عيون معتمدة من الهيئة العامة للطيران المدني
أخصائية فحص عيون معتمدة من هيئة سلامة الطيران المدني تملك أخصائي طب العيون وعلاج الشبكية د. باولا سالفيتي خبرة واسعة في مجالات اختصاصها بالإضافة إلى خبرتها وأبحاثها الموسعة في مجال تشخيص وعلاج أمراض الشبكية، والتي حازت عليها في الولايات المتحدة الأمريكية وفرنسا وإيطاليا. للدكتورة سالفيتي أيضاً اهتمام خاص في فحوص طب الطيران و بأبحاث العلوم العصبية وتقييم وعلاج الأطفال ممن يعانون من عجز في الإبصار بدرجات متفاوتة.
درست الدكتورة سالفيتي الطب وتخصصت في مجال طب العيون في موطنها إيطاليا قبل أن تلتحق ببرنامج الزمالة في كلية هارفارد للطب في بوسطن، الولايات المتحدة الأمريكية. وحازت على الزمالة في طب الشبكية بمعهد شيبينز لأبحاث العيون وفي عيادة ماساشوسيتس للعيون والأذن، كلية هارفارد للطب في بوسطن، قبل أن تتولى منصب طبيب عيون عام واختصاصي طب الشبكية وطب أعصاب العيون في فرنسا. بعد ذلك تم تعيينها مديراً طبياً لمركز Centro Oculistico Bergamasco في إيطاليا.
وضعت الدكتورة سالفيتي العديد من المؤلفات البحثية والمحاضرات التي تم نشرها وتتعلق بمجالات اختصاصها، وهي عو في جمعية أبحاث الإبصار و طب العيون.
انقر هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون[/vc_section][:]

Dr. Darakhshanda Khurram

[:en]


MBBS, FRCS (Glasgow), ICO, MCPS
Consultant Paediatric Ophthalmologist
Dr. Khurram is experienced in Retinopathy of Prematurity screening and management (an eye disease affecting premature babies). She is also experienced in all types of squint (strabismus) surgery (including the use of botulinum toxin).
Dr. Khurram studied medicine at the Rawalpindi Medical College, Pakistan, and undertook a post-graduate fellowship with the Royal College of Surgeons, Glasgow, UK. She completed her fellowship training in Paediatric Ophthalmology and Strabismus at Great Ormond Street Hospital and Moorfields Eye Hospital, in London, UK. While there she worked with some of the most prominent Paediatric Ophthalmologists and gained a world-class knowledge of paediatric ophthalmic surgical procedures.
Dr. Khurram has a highly advanced sub-specialist interest in Paediatric Ophthalmology. Her area of expertise covers the clinical and surgical management of congenital cataracts and congenital glaucoma including augmented filtration procedures and cyclophotocoagulation.
Dr. Khurram is an active researcher, publisher and presenter in her specialist field.
Click here to read more on Paediatric & Strabismus.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage

[:ar]



بكالوريوس في الطب والجراحة، زمالة الكلية الملكية للجراحين (غلاسكو)، زمالة المجلس العالمي لطب العيون، عضو كلية الأطباء والجراحين
استشاري طب عيون الأطفال

درست د. خورام الطب في كلية روالبندي الطبية في باكستان، ثم انضمت إلى برنامج زمالة لدى الكلية الملكية للجراحين في غلاسكو، المملكة المتحدة. أتمت د. خورام تدريب الزمالة في مجال طب عيون الأطفال ومشاكل الحول في مستشفى جريت أورموند ستريت ومستشفى مورفيلدز للعيون بلندن، المملكة المتحدة. وهناك عملت إلى جانب عدد من أبرز أطباء عيون الأطفال واكتسبت معرفة عالمية في مجال جراحات طب عيون الأطفال.لدى د. خورام اهتمام كبير بالاختصاصات الفرعية المتطورة لطب عيون الأطفال. وتشمل خبراتها الإدارة السريرية والجراحية لإعتام عدسة العين الخلقي ومشاكل الجلوكوما الخلقية، بما في ذلك إجراء جراحات تصفية العين المعززة وعمليات cyclophotocoagulation. كما تتمتع بخبرة في فحص وإدارة مشاكل اعتلال الشبكية لدى المواليد الخدج (وهو أحد أمراض العين التي تصيب الأطفال المولودين قبل أوانهم). وبالإضافة إلى ذلك فهي تحمل خبرة واسعة في كافة أنواع جراحات تصحيح الحول (بما في ذلك استخدام مادة توكسين البوتولينوم).
تنشط د. خورام في مجال الأبحاث والتأليف والنشر وطرح الدراسات في مجال اختصاصها.
انقر هنا لقراءة المزيد عن خدمة طب الأطفال والحَوَل.
انقر هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون

[:]

Dr. Mohammed Sohaib Mustafa

[:en] MBBCh, PGDip, MRCOphth, FEBO, FRCS
Consultant Ophthalmic Surgeon, Specialist in Glaucoma and Cataract Surgery
GCAA Approved Specialist Ophthalmologist and Aeromedical Examiner
Associate Professor of Ophthalmology (Adjunct) Dr. Mustafa is a General Ophthalmic Surgeon and subspecialist in Glaucoma & Cataract, with experience in the latest surgical techniques in complex glaucoma management including microdrainage devices, laser treatment and less invasive techniques. Dr. Sohaib is also an experienced Cataract Surgeon. He performs complex Cataract with premium IOL options for both Glaucoma and non-Glaucoma patients. Dr Sohaib specialises in imaging of the eye and Glaucoma assessment and treatment, through Ocular Coherence Tomography, Ocular Ultrasound and Biomicroscopy.
He is also a GCAA certified specialist Ophthalmologist and Aeromedical Examiner. He has many years of experience in management of eye conditions and surgery in aviation medicine.
Dr. Mustafa graduated in Medicine with a Commendation from the UK and undertook his residency in General Ophthalmology in the UK, having worked at The Royal Victoria Eye and Ear Hospital in Dublin, Ireland, and Aberdeen University Hospital in Scotland.
He undertook his fellowship training in Adult and Paediatric Glaucoma at Manchester University Hospital and Moorfields Eye Hospital in London, UK, working under eminent clinicians within the Glaucoma fraternity. He is a certified specialist in the UK and Europe, having also undertaken a Consultant Ophthalmic Surgeon post at Manchester Royal Eye Hospital.
He has attained a Postgraduate Diploma in Cataract and Refractive Surgery from UK and has trained on femtolaser platforms.
He is a member of the Royal College of Ophthalmologists in London and has gained fellowships from the European and United Kingdom boards in Ophthalmology.
His main research interests include compliance and the safety of glaucoma medications, efficacy and safety outcomes of the latest surgical techniques in glaucoma and cataract, including microdrainage devices, and simulation teaching of ocular ultrasound. He has published extensively in peer reviewed journals and presented his work at international and national meetings.
Dr. Mustafa continues to collaborate with colleagues in London on his research interests and latest patient management principles.
Click here to read more on Glaucoma.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage[:ar] بكالوريوس في الطب والجراحة – المملكة المتحدة، دبلوم الدراسات العليا في طب العيون (كتراكت و تصحيح البصر) – المملكة المتحدة، عضو الكلية الملكية لأطباء العيون – المملكة المتحدة، زميل المجلس الأوروبي لأطباء العيون – الاتحاد الأوروبي، زميل الكلية الملكية للجراحين (لتخصص طب العيون) – المملكة المتحدة
مستشار في طب العيون العام و جراحة الجلوكوما والكتاراكت
أخصائي فحص عيون معتمد من الهيئة العامة للطيران المدني
استاذ مشارك في طب العيون (ملحق) يتخصص الدكتور مصطفى في مجال طب وجراحة العيون العامة، باختصاص فرعي في علاج زرق العين (الجلوكوما) وإعتام عدسة العين (الكتراكت)، ويتمتع بخبرة واسعة باستخدام أحدث تقنيات الجراحة لعلاج حالات الجلوكوما المعقدة، بما في ذلك استخدام أجهزة دقيقة لسحب ماء العين والعلاج بالليزر وغيرها من التقنيات الأقل تدخلاً. وهو أيضاً، جراح متمرس في علاج إعتام عدسة العين (كتراكت) ويجري جراحات معقدة لعلاج هذه الحالة باستخدام أجود العدسات الصناعية، و علاج الكتراكت لدى مرضى الجلوكوما. كما يتخصص في تصوير العين وحالات الجلوكوما بواسطة أجهزة التصوير الطبقي للإلتصاق البصري، والتصوير البصري بالأمواج فوق الصوتية والفحص المجهري البيولوجي.
الدكتور مصطفى أخصائي فحص عيون معتمد من قبل الهيئة المدنية للطيران المدني، ويملك خبرة طويلة في مجال علاج أمراض العين وجراحة طب الطيران.
تخرج الدكتور مصطفى من كلية الطب مع مرتبة الشرف في المملكة المتحدة، وأنهى فترة الامتياز في تخصص
طب العيون العام فيها حيث عمل في مستشفى فيكتوريا الملكي للعيون والأذنين في دبلين بأيرلندا، وفي مستشفى جامعة أبردين باسكتلندا.
تلقى الدكتور مصطفى تدريب الزمالة باختصاص علاج الجلوكوما للبالغين والأطفال في مستشفى جامعة مانشستر ومستشفى مورفيلدز لندن للعيون، المملكة المتحدة، حيث أشرف عليه عدد من أبرز الأطباء والأخصائيين في مجال علاج الجلوكوما. وهو أخصائي معتمد في المملكة المتحدة وأوروبا، حيث شغل أيضاً منصب استشاري جراحة العيون لدى مستشفى مانشستر الملكي للعيون.
حاز على شهادة الدبلوم العالي في جراحة إعتام عدسة العين (الكتراكت) و عمليات تصحيح البصر من المملكة المتحدة، وتلقى تدريبًا على استخدام أجهزة الفيمتو-ليزر (femtolaser).
ويشار إلى أن الدكتور محمد مصطفى عضو في الكلية الملكية لأطباء العيون في لندن، وحاز على زمالة المجلسين الأوروبي والبريطاني لطب العيون.
وتتركز اهتمامات الدكتور مصطفى البحثية في مجال سلامة أدوية الجلوكوما ومطابقتها للمعايير، وكفاءة وسلامة مخرجات أحدث التقنيات الجراحية في مجال علاج الجلوكوما وإعتام عدسة العين. وقد نشر مؤلفات عديدة في مجلات طبية هامة كما قدم أعماله خلال مؤتمرات عالمية ومحلية.
يواصل الدكتور مصطفى تعاونه مع زملائه في لندن فيما يتعلق باهتماماته البحثية وأحدث مستجدات ومبادئ التعامل مع المرضى.
انقر هنا لقراءة المزيد عن خدمة علاج الغلوكوما (الزَّرَق).
انقر هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون[:]

Dr. Avinash Gurbaxani

[:en] MB BS, DOMS, FRCS (Ed) (Ophth)
Consultant Ophthalmic Surgeon in Uveitis and Medical Retinal Diseases and Cataract Surgery
Chief of Retina Service, Moorfields UAE
Associate Professor Of Ophthalmology (Adjunct) Dr. Gurbaxani specialises in the assessment and management of uveitis and inflammatory eye disease (uveitis, infectious diseases, autoimmune diseases of the eye) as well as medical retinal disease, such as diabetes, macular degeneration and retinal vascular disease. He has broad experience in the diagnosis and management of complex inflammatory eye diseases, including the use of immunosuppression, as well as in treating retinal disease. Dr Gurbaxani is also skilled in managing complex cataract surgery associated with these diseases.
Dr. Gurbaxani trained in ophthalmology in Oxford and London, working at The Oxford Eye Hospital in Oxford, Kings College Hospital, St. Thomas’ Hospital and Moorfields Eye Hospital in London. He has worked at the prestigious Medical Eye Unit in London as well as completing a Uveitis Fellowship and Medical Retina Fellowship at Moorfields London and the Sydney Eye Hospital in Australia, before returning to Moorfields London as a locum consultant.
Dr Gurbaxani is experienced in initiating research projects and running clinical trials, and has regularly published and presented papers at national and international conferences. He is a member of several professional bodies including the Royal College of Opthalmologists (RCOphth), Royal College of Surgeons of Edinburgh (RCS) (Ed), American Academy of Ophthalmology (AAO).
Click here to read more on Cataract Surgery.
Click here to read more on Macular Degeneration.
Click here to read more on Common Eye Conditions.
Return to Ophthalmologisits Homepage[:ar]بكالوريوس في الطب والجراحة، دبلوم في طب العيون والجراحة، زميل الكلية الملكية للجراحين (إدنبره) (طب العيون)
استشاري جراحة طب العيون لإلتهاب القزحية وأمراض الشبكية و جراحة الكتاراكت
رئيس قسم الشبكية، مورفيلدز الإمارات
استاذ مشارك في طب العيون (ملحق)
ختص الدكتور جوربكساني في تقييم ومعالجة إلتهاب القزحية وإلتهابات العين (إلتهاب القزحية، الأمراض المعدية، وخلل المناعة الذاتية في العين) بالإضافة إلى أمراض الشبكية، مثل مضاعفات السكري، التحلّل البقعي، أمراض الأوعية الدموية في شبكية العين. ولدى الدكتور جوربكساني خبرة واسعة في تشخيص ومعالجة الحالات المعقدة في التهابات العين التي تتضمن مُثبطات المناعة وكذلك علاج أمراض الشبكية. كما يتمتع الدكتور بمهارة عالية في جراحة الكتاراكت المعقدة ذات الصلة بهذه الأمراض. تلقى الدكتور جوربكساني تدريبه في طب العيون في أكسفورد ولندن، وقد عمل في كلٍ من مستشفى أوكسفورد للعيون بأوكسفورد، مستشفى كينجز كوليدج، مستشفى سانت توماس، ومستشفى مورفيلدز لندن للعيون. باشر عمله في وحدة العين الطبية المرموقة بلندن وأتّم زمالته في إلتهاب القزحية وزمالة أخرى في أمراض الشبكية في مستشفى مورفيلدز لندن للعيون ومستشفى سيدني للعيون قبل أن يلتحق مرة أخرى بمستشفى مورفيلدز لندن للعيون ليشغل وظيفة استشاري مُناوب.لدى الدكتور جوربسكاني خبرة واسعة في مباشرة مشاريع البحث العلمي وإجراء تجارب طبية، ولديه بحوث منشورة بإستمرار ليتم تقديمها في المؤتمرات الوطنية والعالمية. عضو في العديد من الهيئات المهنية التى تشمل الكلية الملكية لطب العيون، كلية الجراحين الملكية بإدنبرة، والأكاديمية الأمريكية لطب العيون.
انقر هنا لقراءة المزيد عن التحلل البقعي
انقر هنا لقراءة المزيد عن حالات العين الشائعة
العودة إلى صفحة أطباء العيون[:]

Dubai-based eye health expert encourages regular Glaucoma screening in the UAE; link to Diabetes increases risk of Glaucoma

[:en]10 March 2015 (Dubai, United Arab Emirates): Marking the conclusion of World Glaucoma Awareness Week 2015 (March 8-14, held under the theme of BIG – Beat Invisible Glaucoma), the Glaucoma expert at Moorfields Eye Hospital Dubai is calling for continued and greater awareness of the risk of this disease and highlighting the need for regular screening for older citizens and residents in the UAE to prevent Glaucoma blindness. The World Health Organisation estimates that Glaucoma affects around 60 million people globally.
Glaucoma is the second leading cause of blindness worldwide and the number one cause of irreversible blindness. However, the disease is treatable and blindness can be prevented through early diagnosis. Although children and young adults can be affected by Glaucoma, high risk groups include middle aged and older people (with an increasing risk from 40 years of age up), uncontrolled diabetics and those with a family history of glaucoma.
Moorfields Eye Hospital Dubai (Moorfields) is highlighting the importance of Glaucoma awareness, and stressing the need for early detection. Screening for the disease and then compliance with the treatment regime are two important messages for the community.
According to the World Health Organization, the number of people estimated to be blind as a result of primary glaucoma is 4.5 million, accounting for slightly more than 12 per cent of all global blindness. The primary risk factors that are linked to the individual and the onset of the disease are age and genetic predisposition. The incidence of some types of Glaucoma rises with age and its progression is more frequent in people of African origin.
Glaucoma is called “the sneak thief of sight” because there are no symptoms and once vision is lost, it is permanent. As much as 40 per cent of the field of vision can be lost without a person noticing. According to the Glaucoma Research Foundation, there are currently 2.7 million people in the United States over the age 40 with glaucoma. Experts estimate that half of these people do not know that they have the disease. The National Eye Institute projects that this number will reach 4.2 million by 2030, a 58 percent increase.
Are there symptoms?
“Unfortunately, many people with glaucoma are unaware that they have it until there is a large amount of irreversible vision loss,” says Dr Mohammed Sohaib Mustafa, Consultant Glaucoma Surgeon at Moorfields Eye Hospital Dubai, speaking on the sidelines of a Glaucoma symposium in Dubai, where he presented the latest advances in Glaucoma surgery. “Glaucoma has no symptoms in its early stages and up to 40 per cent loss of sight can occur before any problem is noticed by the sufferer. This is why we are advising the community in the UAE – and especially those over the age of 40 – to undertake regular screening every year. It really could save your eyesight. We have a relatively young population in the UAE but with a high incidence of diabetes and so, as the population ages, there is the risk of an increase of Glaucoma.” Glaucoma is a group of eye diseases that cause progressive damage of the optic nerve. If left untreated, most types of glaucoma result (without any warning or obvious symptoms to the patient) in increasing visual damage and may lead to blindness. Once this has happened, the visual damage is permanent, which is why glaucoma is described as the “silent blinding disease” or the “sneak thief of sight”.
Is there a cure?
There is no simple cure for glaucoma yet, however it can definitely be treated and blindness can be prevented through early diagnosis and acceptance of treatment. Treatment with eye drops or surgery (conventional or laser) can halt or slow-down the disease and prevent further vision loss. Research aims to uncover the various mechanisms for the abnormal levels of intra-ocular pressure, nerve damage and the role of genes. Early detection is essential to limiting visual impairment and preventing the progression towards severe visual handicap or blindness. An eye-care professional can detect glaucoma in its early stages.
Screening
Screening for Glaucoma involves a mandatory eye pressure check, evaluation of the health of the optic nerve at the back of the eye by a specialist doctor and visual fields test if any changes are seen at the previous exams. All tests are pain free and easy to assess the disease when performed in proper ophthalmic hospitals or clinics. They should be done every 12 months as screening and can be accompanied by an optic nerve photo if needed.
“In most cases, glaucoma appears after the fourth decade of life, and its frequency increases with age,” adds Dr Mohammed Sohaib Mustafa. “There is no clearly established difference in glaucoma incidence between men and women. Other risk factors include genetics and family history, and other health conditions like uncontrolled diabetes, which is very common in the UAE. There is a wide ranging spectrum of cases ranging from patients who have established early glaucoma and are compliant with treatment, to patients who have uncontrolled glaucoma and either non-compliant with medication or indeed as we have highlighted, don’t know they have the condition.”

Cyclodiode Laser Treatment

The diode laser is a highly concentrated beam of light, which can be used to target and treat a selected area. Sometimes, laser treatment is recommended in order to avoid or delay the need for more invasive surgery. The diode laser is used to produce very small burns in the ciliary body, which produces the watery fluid called aqueous humour, and is situated behind the iris (coloured part of your eye). The reduced production of aqueous humour causes the eye pressure to fall.

Vitrectomy Surgery

A vitrectomy surgery is microsurgery performed to remove the jelly and replace it by a saline solution, gas or a special type of silicone oil. The most common reasons for operating on the retina are retinal detachment, diabetes and scarring on the retina.
For more information about vitrectomy surgery in Dubai, contact us today.

Squint Surgery in Adults

This information aims to answer some of the questions you may have about squint surgery. However, it does not cover everything as every patient and squint is different. Your surgeon will discuss your particular case with you. Please ask the clinical staff about anything you want to be made clear.

What is the aim of surgery?

  • To improve the alignment of the eyes, to make the squint smaller in size.
  • In some patients, to reduce or try to eliminate double vision.
  • Occasionally to improve an abnormal position of the head.

How is the surgery done?

Squint surgery is a very common eye operation. It usually involves tightening or moving one or more of the outside eye muscles which move the eye. These muscles are attached quite close to the front of the eye under the conjunctiva, the clear surface layer. The eye is never taken out of the socket during surgery. Stitches are used to attach the muscles in their new positions.
Squint surgery is nearly always a day case procedure so you should be in and out of hospital on the same day.
There are two kinds of squint operation – adjustable and non-adjustable:

Non adjustable surgery

The operation is usually carried out under general anaesthetic. The operation usually takes up to 60 minutes depending on the number of muscles that need surgery. When you have recovered from the anaesthetic and the nurses are happy for you to be discharged, you are free to go home – usually a few hours later.

Adjustable surgery

Squint surgery using an adjustable suture may give a better result in certain types of squint e.g. patients who have had a squint operation before, patients with a squint due to injury or patients with thyroid eye problems.

Part 1 – The main operation

The main part of the operation is carried out in the operating theatre usually under general anaesthetic (with you asleep).

Part 2 – Adjusting the stitch

Once you have woken up from the anesthetic the final position of the muscles is adjusted when you are awake and able to look at a target. This is particularly useful for treating double vision. If you wear glasses for distance or near, these will need to be brought in with you for this part of the operation. Adjustment is usually done on the ward, after drops of anaesthetic have been put into the eye to take away any pain. You may however feel a pressure sensation.

Before the day of surgery

A pre-assessment is performed in the weeks leading up to the operation date.

What happens on the day of surgery?

You will be asked to come early so that you can be prepared for surgery. You should not drink or eat before the operation: the exact timings of this will be given before the day of the operation. Before being discharged after the operation, you will receive eye drops with instructions and a follow up appointment.

Does the surgery cure the squint?

Overall about 90% patients feel some improvement in their squint after surgery. The amount of correction that is right for one patient may be too much or too little for another with exactly the same size squint, so that the squint may not be completely corrected by the operation. Although the eyes may be straight just after surgery, many patients require more than one operation in their lifetime. If the squint returns it may drift in either the same or opposite direction. We can’t predict when that drift may occur.

What are the risks of the operation?

Squint surgery is generally a safe procedure. However, as with any operation, complications can and do occur. Generally these are relatively minor but on rare occasions they may be serious.

  • Under and overcorrection

As the results of squint surgery are not completely predictable, the original squint may still be present (undercorrection) or the squint direction may change over (overcorrection). Occasionally a different type of squint may occur. These problems may require another operation.

  • Double vision

You may experience double vision after surgery, as your brain adjusts to the new position of the eyes. This is common and often settles in days or weeks but may take months to improve. Some patients may continue to experience double vision when they look to the side in order to achieve a good effect when the eyes look straight ahead. Rarely, double vision whilst looking straight ahead can be permanent in which case further treatment might be needed. If you already experience double vision, you might experience a different type of double vision after surgery. Botulinum toxin injections are sometimes performed before surgery to assess your risk of this.

  • Allergy/stitches

Some patients may have a mild allergic reaction to the medication they have been prescribed after surgery. This results in itching/irritation and some redness and puffiness of the eyelids. It usually settles very quickly when the drops are stopped. You may develop an infection or abscess around the stitches. This is more likely to occur if you go swimming within the first four weeks after surgery. A cyst can develop over the site of the stitches, which occasionally needs further surgery to remove it.

  • Redness

The redness in the eye can take as long as 3 months to go away. Occasionally the eye does not completely return to its normal colour, particularly with repeated operations.

  • Scarring

Most of the scarring of the conjunctiva (skin of the eye) is not noticeable by three months, but occasionally visible scars will remain, especially with repeat operations.

  • Lost or slipped muscle

Rarely one of the eye muscles may slip back from its new position during the operation or shortly afterwards. If this occurs, the eye is less able to move around and, if severe, further surgery can be required. Sometimes it is not possible to correct this. The risk of slipped muscle requiring further surgery is about 1 in 1,000.

  • Needle penetration

If the stitches are too deep or the white of the eye is thin, a small hole in the eye may occur, which may require antibiotic treatment and possibly some laser treatment to seal the puncture site. Depending on the location of the hole, the sight may be affected. The risk of the needle passing too deeply is about 2%.

  • Anterior segment ischaemia

The blood circulation to the front of the eye can very rarely be reduced following surgery, producing a dilated pupil and blurred vision. This usually only occurs in patients who have had multiple surgeries. The risk is about 1 in 13,000 cases.

  • Infection

Infection is a rare complication but the risk  increases if drops are not instilled as directed and treatment not sought promptly. Significant infection is extremely rare but in the worst cases can cause loss of vision or the eye (endophthalmitis, orbital cellulitis).

  • Loss of vision

Although very rare, loss of vision in the eye being operated can occur from this surgery. Risk of serious damage to the eye or vision is approximately 1 in 30,000.

  • Anaesthetic risks

Anaesthetics are usually safe but there are small and potentially serious risks. Unpredictable reactions occur in around 1 in 20,000 cases and unfortunately death in around 1 in 100,000.
Remember: these complications are detailed for your information and that the vast majority of people have no significant problems. After the operation the eye(s) will be swollen, red and sore and the vision may be blurry. The eye may be quite painful.
Start the drops you have been prescribed that evening, and painkillers such as paracetamol and ibuprofen can be taken. The pain usually wears off within a few days. The redness and discomfort can last for up to 3 months particularly with adjustable and repeat squint operations.
You should not sign any legal documents or drive for 48 hours after the general anaesthetic.
We would advise that you may need one or occasionally two weeks off work. Work and normal activities including sport can be resumed as soon as you feel comfortable to do so. It is quite safe to use the eyes for visual tasks, for example reading, watching television. You should return for follow up as advised.

Summary of care after the operation

  • Use the eye drops
  • Use painkillers such as paracetamol and ibuprofen if the eyes are painful
  • Use cooled boiled water and a clean tissue or cotton wool to clean any stickiness of the eyes and avoid water entering the eyes from the bath or shower for the first two weeks
  • Don’t rub the eye(s) as this may loosen the stitches
  • No swimming for 4 weeks
  • Attend the postop clinic appointment
  • Continue using glasses if you have them
  • Avoid contact lens wear in the operated eye(s) until advised it is safe by the doctor or orthoptist

Selective Laser Trabeculoplasty

Selective Laser Trabeculoplasty (SLT) is a procedure used to reduce the pressure in the eye (also known as intra-ocular pressure). A laser beam is applied to the drainage channels, which helps to unclog them. This means the aqeous humour flows through the channels better, reducing the pressure in the eye. This is not a permanent treatment, and may need to be repeated in the future to control the eye pressures adequately. The procedure does not require admission to hospital and is carried out in the outpatients department.

Refractive Surgery

Most refractive errors can be corrected (or at least improved) by means of Refractive Surgery. This is a generic term, which comprises both Laser Refractive Surgery and correction by means of lens implants inside the eye. The latter is called Phakic intraocular lens (IOL) surgery.
Most refractive errors can be corrected (or at least improved) by means of Refractive Surgery. This is a generic term, which comprises both Laser Refractive Surgery and correction by means of lens implants inside the eye.

Presbyopia

Presbyopia is a vision condition which makes it difficult to focus on close objects. During middle age, usually beginning in the 40s, people experience blurred vision at near points, such as when reading, sewing or working at the computer.
Presbyopia is a natural part of the ageing process of the eye. It is not a disease, and it cannot be prevented. Presbyopia is diagnosed with a routine eye examination. Eyeglasses with bifocal or progressive addition lenses are the most common correction for presbyopia.